Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 3 of 3 entries
Sorted by: Best Match Show Resources per page
[No title available]

Expert opinion on therapeutic targets

Monaghan TM, Seekatz AM, Mullish BH, Moore-Gillon CCER, Dawson LF, Ahmed A, Kao D, Chan WC.
PMID: 34793686
Expert Opin Ther Targets. 2021 Dec 02;1-15. doi: 10.1080/14728222.2021.2008907. Epub 2021 Dec 02.

AREAS COVERED: We searched PubMed and Web of Science databases for articles identifying novel therapeutic targets or treatments for EXPERT OPINION: Considerable progress has been made in the development of new anti-CDI drug candidates. Nevertheless, a greater comprehension of...

Cite
Monaghan TM, Seekatz AM, Mullish BH, et al. . Expert Opin Ther Targets. 2021;1-15doi: 10.1080/14728222.2021.2008907.
Monaghan, T. M., Seekatz, A. M., Mullish, B. H., Moore-Gillon, C. C. E. R., Dawson, L. F., Ahmed, A., Kao, D., & Chan, W. C. (2021). . Expert opinion on therapeutic targets, 1-15. https://doi.org/10.1080/14728222.2021.2008907
Monaghan, Tanya M, et al. "." Expert opinion on therapeutic targets vol. (2021): 1-15. doi: https://doi.org/10.1080/14728222.2021.2008907
Monaghan TM, Seekatz AM, Mullish BH, Moore-Gillon CCER, Dawson LF, Ahmed A, Kao D, Chan WC. . Expert Opin Ther Targets. 2021 Dec 02;1-15. doi: 10.1080/14728222.2021.2008907. Epub 2021 Dec 02. PMID: 34793686.
Copy Download .nbib Format: NLM
[No title available]

Expert opinion on therapeutic targets

Monaghan TM, Seekatz AM, Mullish BH, Moore-Gillon CCER, Dawson LF, Ahmed A, Kao D, Chan WC.
PMID: 34793686
Expert Opin Ther Targets. 2021 Nov;25(11):949-963. doi: 10.1080/14728222.2021.2008907. Epub 2021 Dec 02.

AREAS COVERED: We searched PubMed and Web of Science databases for articles identifying novel therapeutic targets or treatments for EXPERT OPINION: Considerable progress has been made in the development of new anti-CDI drug candidates. Nevertheless, a greater comprehension of...

Cite
Monaghan TM, Seekatz AM, Mullish BH, et al. . Expert Opin Ther Targets. 2021;25(11):949-963doi: 10.1080/14728222.2021.2008907.
Monaghan, T. M., Seekatz, A. M., Mullish, B. H., Moore-Gillon, C. C. E. R., Dawson, L. F., Ahmed, A., Kao, D., & Chan, W. C. (2021). . Expert opinion on therapeutic targets, 25(11), 949-963. https://doi.org/10.1080/14728222.2021.2008907
Monaghan, Tanya M, et al. "." Expert opinion on therapeutic targets vol. 25,11 (2021): 949-963. doi: https://doi.org/10.1080/14728222.2021.2008907
Monaghan TM, Seekatz AM, Mullish BH, Moore-Gillon CCER, Dawson LF, Ahmed A, Kao D, Chan WC. . Expert Opin Ther Targets. 2021 Nov;25(11):949-963. doi: 10.1080/14728222.2021.2008907. Epub 2021 Dec 02. PMID: 34793686.
Copy Download .nbib Format: NLM
A Case of Severe Vedolizumab-induced Liver Injury.

Inflammatory bowel diseases

Hsu C, Sikafi R, Moore-Gillon C, Goldin R, Possamai L.
PMID: 34291799
Inflamm Bowel Dis. 2021 Nov 15;27(12):e148-e149. doi: 10.1093/ibd/izab160.

No abstract available.

Cite
Hsu C, Sikafi R, Moore-Gillon C, et al. A Case of Severe Vedolizumab-induced Liver Injury. Inflamm Bowel Dis. 2021;27(12):e148-e149doi: 10.1093/ibd/izab160.
Hsu, C., Sikafi, R., Moore-Gillon, C., Goldin, R., & Possamai, L. (2021). A Case of Severe Vedolizumab-induced Liver Injury. Inflammatory bowel diseases, 27(12), e148-e149. https://doi.org/10.1093/ibd/izab160
Hsu, Catherine, et al. "A Case of Severe Vedolizumab-induced Liver Injury." Inflammatory bowel diseases vol. 27,12 (2021): e148-e149. doi: https://doi.org/10.1093/ibd/izab160
Hsu C, Sikafi R, Moore-Gillon C, Goldin R, Possamai L. A Case of Severe Vedolizumab-induced Liver Injury. Inflamm Bowel Dis. 2021 Nov 15;27(12):e148-e149. doi: 10.1093/ibd/izab160. PMID: 34291799.
Copy Download .nbib Format: NLM
Showing 1 to 3 of 3 entries